Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
Translational Therapeutics (United States) · University of Pennsylvania · +13 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
737
total citations
- FWCI
- 74.34
- Percentile
- 100%
- References
- 29
Citations per year
Authors
17- MCMarina CuchelCorresponding
Translational Therapeutics (United States), University of Pennsylvania
- EAEmma A. Meagher
Translational Therapeutics (United States), University of Pennsylvania
- HDHendrik du Toit Theron
Netcare Unitas Hospital
- DBDirk Blom
University of Cape Town, South African Medical Research Council
- ADA. David Marais
South African Medical Research Council, University of Cape Town
Topics & keywords
Topics
Keywords
- Microsomal triglyceride transfer protein
- Triglyceride
- Medicine
- Internal medicine
- Endocrinology
- Chemistry
- Pharmacology
- Cholesterol
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.